NCT00140998View on ClinicalTrials.gov

Estrogen Treatment (Oral vs. Patches) in Turner Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

January 31, 2001

Study Completion Date

June 30, 2004

Conditions
Turner SyndromeHypogonadismPremature Ovarian Failure
Interventions
DRUG

17 beta estradiol

Trial Locations (1)

32207

Nemours Children's Clinic, Jacksonville

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

Nemours Children's Clinic

OTHER

NCT00140998 - Estrogen Treatment (Oral vs. Patches) in Turner Syndrome | Biotech Hunter | Biotech Hunter